Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor

Find Full text
Publication year
2020
Author(s)
Verdoia, Monica
Nardin, M.
Gioscia, Rocco
Negro, F.
Marcolongo, M.
Suryapranata, H.
Kedhi, Elvin
Luca, G. De
Source
Vascular Pharmacology, 132, (2020), article 106765
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/226229   https://hdl.handle.net/2066/226229
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.